Vascular Closure Devices

This channel includes news and new technology innovations for vascular closure devices used to rapidly seal and achive hemostatsis at vascular access sites in interventional cardiology procedures.

Artio Medical Receives FDA Clearance for Solus Gold Embolization Device
March 29, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, has received US Food and Drug ...
Plug-based Vascular Closure Following TAVR Offers Shorter Hemostasis Time Than Suture-based Devices
November 9, 2021 — Results from the largest randomized trial available comparing different closure device strategies following transcatheter aortic valve replacement (TAVR) found that a plug-based ...
VIDEO: Radial Hemostasis Reduced by 50 Percent With StatSeal in Combination With TR Band
Arnold Seto, M.D., MPA, FSCAI, chief of cardiology, Long Beach Veterans Affairs Medical Center and director, interventional cardiology research, UCI Health, and Jordan Safirstein, M.D., FSCAI ...
Radial Hemostasis Time Cut by 50 Percent With StatSeal in Combination With TR Band
April 28, 2021 — A new study reveals the use of a potassium ferrate hemostatic patch (PFHP) reduces the time to hemostasis for patients receiving radial artery access cardiac catherization. The ...

Results from Largest Ever Real-World Evaluation of the MANTA Device Demonstrated Safety and Effectiveness with Low Complication Rates and a Short Learning Curve

News | Vascular Closure Devices

Co-Author of the Karolinska 1000 Consecutive MANTA Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference

September 16, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced that Dr. Magnus ...

September 16, 2022

Cardiac Implants LLC has announced the successful initial deployment of its Annuloplasty ring with implementation of a therapeutic adjustment procedure using its innovative Tri-Ring percutaneous annuloplasty device.

News | Heart Valve Technology

Cardiac Implants Announces Successful Therapeutic Adjustment Procedure Using Tri-Ring Percutaneous Annuloplasty Device

September 15, 2022 — Cardiac Implants LLC has announced the successful initial deployment of its Annuloplasty ring with ...

September 15, 2022

Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, has received US Food and Drug Administration (FDA) clearance for its Solus Gold Embolization Device, a next-generation product for peripheral vascular occlusion.

News | Embolization devices

Artio Medical Receives FDA Clearance for Solus Gold Embolization Device

March 29, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral ...

March 29, 2022

The Teleflex Manta large bore vascular closure device #TCT2021

News | Vascular Closure Devices

Plug-based Vascular Closure Following TAVR Offers Shorter Hemostasis Time Than Suture-based Devices

November 9, 2021 — Results from the largest randomized trial available comparing different closure device strategies ...

November 09, 2021

Leveraging Vivasure Medical’s PerQseal vascular closure device technology, PerQseal Blue consists of an intravascular patch designed to seal the vessel from the inside, returning the vein to its natural state after it dissolves over time, so no foreign bodies are left behind.

News | Vascular Closure Devices

Vivasure Medical is Developing a Sutureless Venous Closure Device for Transcatheter Valve Procedures

July 15, 2021 — Vivasure Medical announced its development program for PerQseal Blue, a sutureless and fully ...

July 15, 2021

Videos | Radial Access

VIDEO: Radial Hemostasis Reduced by 50 Percent With StatSeal in Combination With TR Band

Arnold Seto, M.D., MPA, FSCAI, chief of cardiology, Long Beach Veterans Affairs Medical Center and director ...

May 06, 2021

The STAT2 trial used a combination of the Biolife Statseal potassium ferrate hemostatic patch and a Terumo TR Band to reduce radial access arteriotomy site hemostasis by 50 percent.

News | Radial Access | Dave Fornell, Editor

Radial Hemostasis Time Cut by 50 Percent With StatSeal in Combination With TR Band

April 28, 2021 — A new study reveals the use of a potassium ferrate hemostatic patch (PFHP) reduces the time to ...

April 28, 2021

The FDA’s market clearance occurred once the agency reviewed EnsiteVascular’s Section 510(k) premarket notification of intent to market the SiteSeal SV device and determined it is substantially equivalent for the indication for use stated: brachial artery closure. Previously, EnsiteVascular received FDA market clearance for SiteSeal SV for radial artery closure.

News | Hemostasis Management

FDA Clears SiteSeal SV Vascular Closure Device for the Brachial Arteries

April 21, 2021 — EnsiteVascular announced it received its second U.S. Food and Drug Administration (FDA) market ...

April 21, 2021

News | Vascular Closure Devices

Vasorum Partners With Veryan to Commercialize of New Vascular Closure Device in U.S.

August 17, 2020 — Veryan Medical announced it will support Vasorum in the commercialization of the Celt atrial closure ...

August 17, 2020

News | Radial Access

Merit Medical Announces its EVOlution in Radial Hemostasis in Europe

December 30, 2019 — Merit Medical Systems Inc., a leading manufacturer of proprietary devices used primarily in ...

December 30, 2019

The Saranas Early Bird Bleed Monitoring System offers real-time detection and monitoring of transcatheter intervention vascular access site bleed complications.

News | Vascular Access

Early Bird Bleed Monitoring System Used in First Commercial U.S. Patient

November 6, 2019 — Saranas Inc. announced completion of the first U.S. commercial case using its Early Bird Bleed ...

November 07, 2019

Videos | Vascular Closure Devices

VIDEO: Use of Large Bore Vascular Closure

Ashish Pershad, M.D., chief of interventional cardiology, Banner University Medical Center, Phoenix, explains the trend ...

October 17, 2019

Technology | Radial Access

Cordis Announces U.S. Launch of Radial 360 Portfolio

May 15, 2019 — Cordis, a Cardinal Health company, recently announced the full U.S. launch of its Radial 360 portfolio ...

May 15, 2019

Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore Manta Vascular Closure Device. It is designed to close large puncture sites in the femoral artery from larger sized transcatheter devices, including the Impella heart pump, endovascular stent grafts and transcatheter valves.

Technology | Vascular Closure Devices

Large-Bore Vascular Closure Device Cleared by the FDA

April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore ...

April 03, 2019

Technology | Vascular Closure Devices

FDA Approves Vascade MVP Vascular Closure System

December 20, 2018 — Cardiva Medical Inc. announced the company has received premarket approval (PMA) from the U.S. Food ...

December 20, 2018